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The extended release spheroids was Formulated using Ethyl Cellulose, Povidone and Triacetin as a Coating material and 
evaluated the effect of change in weight build up on drug release profile. Optimization of extended release coating by 19% 
build up of EC/PVP-K30 of formulation (F4), in which the formulation is formulated by Reservoir system and the drug 
release depends on coating thickness of EC/PVP-K30. As concentration of coating weight buildup increases. which 
increases the thickness of coating on the reservoir system hence release retarded and transformed into an extended release 
system.  
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INTRODUCTION 
Major goal behind the project is to improved efficacy as 
well as pharmacological response to be achieved by 
formulation and evaluation of extended release dosage 
form. Pharmacokinetics parameters of extended release 
pellets altered by means of weight build up a method 
that ultimately affects changes in bioavailability. 
Amount of drug is released at a controlled rate 
(maintenance dose, DM) to maintain the said blood 
levels for some desirable period of time.1,2 in this 
Experimental Work special emphasis has been given to 
increase the surface area of MUPS by increase in 
thickness of coating layer for the individual pellets 
Pellets are defined as geometrical agglomerates 
obtained from diverse starting materials (sucrose, starch, 
microcrystalline cellulose, etc) and can be produced by 
different process conditions.2 
Above study was designed to develop a better 
efficacious formulation for drugs having short 
biological half life and low bioavailability. The dosage 
form may also improve solubility in water results 
improve pharmacological action.  
 
METHOD AND MATERIAL EMPLOYED 
Material:- The drug Duloxetine HCL was obtained 
from alembic ltd. Hypromellose, ethyl cellulose (ethocel 
45 cps) were procure from the dow chemicals. Isopropyl 
alcohol (ipa), Methylene chloride was obtained from 
Deepak fertilizer; Microcrystalline cellulose (avicel ph 
102) was procured from Fmc Bio.Poly. Triacetin 
collected form Merck and Purified Talc was obtained 
from Barretts Minerals. 
A) Method Employed for Preparation of Core 
Pellets and Coating  
PREPARATION OF CORE PELLETS: 
Drug Mixing and Wet Massing: During the Pellets 
Preparation, dry powder mixture was prepared by 
mixing drug, excipient in a rapid mixer granulator 
(Ganson Pvt. Ltd. 100L, USA) at slow impeller speed 
for about 15 min. The blend was granulated using 
purified water as granulating fluid. Additional purified 
water, if required was incorporated during granulation 
to obtain wet mass suitable for extrusion and obtaining 
the quality pellets in terms of roundness.   
Extrusion / Spheronization: The wet mass was 
extruded through a screen extruder (EXDC(R) JS 60G, 
Fuji Paudal Co. Ltd., Japan) equipped with a standard 
screen 1.0 mm diameter aperture and the rolls rotating at 
40-60 RPM. The extruded were transferred to a 
spheronizer (QJ-400TG, , Fuji Paudal Co. Ltd., Japan) 
equipped with a crosshatch plate 1mm and processed at 
15-250 rpm for 1-2 min. followed by 850-950 rpm for 
1-5 min. 
Drying and Sifting: The resultant pellets were dried in 
a fluidized bed dryer (100L, Pam-Glatt Pvt. Ltd., 
Germany) with an inlet temp. at 55-65°C till loss of 
drying achieved NMT 3.0%. The dried pellets were 
sifted through BSS 12 (1405 microns) and retentions 
were discarded. 
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Method employed for Coating of Core spheroids 
Preparation of Coating Solution for spraying on 
Core spheroids 
Extended Release coating of Core Spheroids 
Sifting of Coated Spheroids    
 
 
 
   
 
 
 
 
 
Overview of the Formulation of ER Pellets 
1 and 2 
1) Increasing thickness of MUPS by Employing the 
Coating Solution : 
FORMULATIONS 
Coating 
solution 
required 
for 50 kg 
spheroids 
F1 
(16%) 
F2 
(17%) 
F3 
(18%) 
F4 
(19%) 
F5 
(20%) 
200L 212.5L 225L 237.5L 250 L 
EVALUATION OF COATED SPHEROIDS 
1) The ER coated spheroids were firstly evaluated 
for sufficient flow properties, using various 
characteristics parameters such as  
A) Bulk Density 
B) Tapped density 
C) Compressibility index 
D) Hausner ratio 
W(g)  (V0)  (V)  BD  TD  CI  HR  
50.0 67.0 60.0 0.75  0.83  10.4 1.12  
50.0 66.8 60.0 0.75 0.83 10.2 1.11 
50.0 67.0 60.1 0.75 0.83 10.3 1.11 
Avg 
±S.D 
66.9 
±0.12 
180.1 
±0.06 
0.75±
0.0 
0.83
±0.0 
10.3±
0.13 
1.11
±0.0 
W= Weight of drug taken, V0 = Initial volume, V= 
Final volume 
2) IN VITRO DRUG RELEASE OF 
FORMULATED FORMULATIONS 
The in-vitro dissolution studies were carried out using 
USP 24 dissolution apparatus  Test was carried out for a 
total period of 24 hours. 
2) Percentage drug release of all formulations 
% cumulative drug Release 
Time Innovator F1 F2 F3 F4 F5 
1hr 9 12 10 7 6 4 
4hrs 49 69 60 53 48 40 
12hrs 89 93 87 81 78 63 
24hrs 101 101 99 95 91 74 
 
The result shows that dissolution depends on particle 
size and surface area. Greater the particle size less is the 
surface area and less will be the dissolution. Effect of 
change in weight build up with increase in thickness of 
coating layer on drug release profile. 
 
RESULT & DISCUSSION  
Based on the literature search and reference product 
review, prototype development initiated with 
preparation of core spheroids by extrusion/ 
spheronization technique followed by coating the 
spheroids with an extended release rate controlling 
polymer by employing Wruster Coater 
Optimization of extended release coating builds up 19% 
build up of EC/PVP-K30 of formulation (F4), in which 
the formulation is formulated by Reservoir system and 
the drug release depends on coating  thickness of 
EC/PVP-K30 as concentration of  coating weight 
buildup  increases it increases the thickness of coating 
on the reservoir system hence release retarded and 
transformed into an Extended release system which 
shows The result  better to that of Innovator and meets 
up the requirements of extended release system. The 
pellets were analyzed for the parameters such as bulk 
density, tapped density, compressibility index, 
Hausner’s ratio and the results were found within the 
limits 
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